Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome?
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 20, Issue 2, Pages 209-222
Publisher
Informa Healthcare
Online
2016-02-14
DOI
10.1517/14728222.2016.1086751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases
- (2015) Jonathan P. Sherlock et al. CURRENT OPINION IN RHEUMATOLOGY
- Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
- (2015) Aoi Shiomi et al. MEDIATORS OF INFLAMMATION
- Novel therapeutic targets in rheumatoid arthritis
- (2015) Marije I. Koenders et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments
- (2014) Dirk W. Luchtman et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
- (2014) Sheng Xiao et al. IMMUNITY
- Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients
- (2014) Mohan S. Maddur et al. IMMUNOLOGIC RESEARCH
- Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF- -Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression
- (2014) S. Xiao et al. JOURNAL OF IMMUNOLOGY
- Pharmacologic Inhibition of ROR t Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo
- (2014) J. Skepner et al. JOURNAL OF IMMUNOLOGY
- Curcumin ameliorates rat experimental autoimmune neuritis
- (2014) Fuyu Han et al. JOURNAL OF NEUROSCIENCE RESEARCH
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study
- (2014) Tsutomu Takeuchi et al. Modern Rheumatology
- Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
- (2014) Bianca van den Berg et al. Nature Reviews Neurology
- More Severe Manifestations and Poorer Short-Term Prognosis of Ganglioside-Associated Guillain-Barré Syndrome in Northeast China
- (2014) Xiujuan Wu et al. PLoS One
- Mitigated Tregs and Augmented Th17 Cells and Cytokines are Associated with Severity of Experimental Autoimmune Neuritis
- (2014) X. Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Targeting Th17 cells in autoimmune diseases
- (2014) Jianfei Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- The Role of T Helper (TH)17 Cells as a Double-Edged Sword in the Interplay of Infection and Autoimmunity with a Focus on Xenobiotic-Induced Immunomodulation
- (2013) Nasr Y. A. Hemdan et al. Clinical & Developmental Immunology
- Th1/Th2/Th17/Treg cytokines in Guillain–Barré syndrome and experimental autoimmune neuritis
- (2013) Hong-Liang Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Surgery itself does not trigger Guillain-Barré syndrome
- (2013) B. R. Wakerley et al. EUROPEAN JOURNAL OF NEUROLOGY
- Infectious and noninfectious triggers in Guillain–Barré syndrome
- (2013) Benjamin R Wakerley et al. Expert Review of Clinical Immunology
- Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barré Syndrome
- (2013) Rong kun Han et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models
- (2013) Xu Wang et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study
- (2013) K.A. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Th17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
- (2013) Wim B. van den Berg et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- Th17 Cells
- (2012) Mohan S. Maddur et al. AMERICAN JOURNAL OF PATHOLOGY
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Identification of early gene expression changes during human Th17 cell differentiation
- (2012) S. Tuomela et al. BLOOD
- Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
- (2012) P. Rich et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
- (2012) Shu Zhu et al. CLINICAL SCIENCE
- IL-23: One cytokine in control of autoimmunity
- (2012) Andrew L. Croxford et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Small molecule inhibitors of RORγt: Targeting Th17 cells and other applications
- (2012) Jun R. Huh et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Increased incidence of Guillain-Barré syndrome after surgery
- (2012) H. Gensicke et al. EUROPEAN JOURNAL OF NEUROLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain–Barré syndrome
- (2012) Song-lan Liang et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- IFN-γ deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response
- (2012) Hong-Liang Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Recent developments and future directions in Guillain-Barré syndrome
- (2012) Helmar C. Lehmann et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokines in Guillain-Barré Syndrome
- (2011) Doris Lambracht-Washington et al. ARCHIVES OF NEUROLOGY
- TH1 and TH2 Response to Campylobacter jejuni Antigen in Guillain-Barré Syndrome
- (2011) Kishan K. Nyati et al. ARCHIVES OF NEUROLOGY
- Briakinumab for the Treatment of Plaque Psoriasis
- (2011) Pawel Traczewski et al. BIODRUGS
- Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells
- (2011) Xiao-Li Li et al. CELLULAR IMMUNOLOGY
- Functional Specialization of Interleukin-17 Family Members
- (2011) Yoichiro Iwakura et al. IMMUNITY
- Interleukin-23: as a drug target for autoimmune inflammatory diseases
- (2011) Chunlei Tang et al. IMMUNOLOGY
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein
- (2011) Tao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis of Digoxin That Antagonizes RORγt Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production
- (2011) Saori Fujita-Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis
- (2011) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Notch Signaling Regulates Mouse and Human Th17 Differentiation
- (2011) S. Keerthivasan et al. JOURNAL OF IMMUNOLOGY
- Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study
- (2011) Yukari Sekiguchi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Novel treatment for immune neuropathies on the horizon
- (2011) Hans-Peter Hartung et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
- (2011) Jun R. Huh et al. NATURE
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- (2011) Laura A. Solt et al. NATURE
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages
- (2011) Wei Liao et al. NATURE IMMUNOLOGY
- Doxycycline Attenuates Peripheral Inflammation in Rat Experimental Autoimmune Neuritis
- (2011) Chenju Yi et al. NEUROCHEMICAL RESEARCH
- Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis
- (2011) James J. Sejvar et al. NEUROEPIDEMIOLOGY
- Signaling of interleukin-17 family cytokines in immunity and inflammation
- (2010) Seon Hee Chang et al. CELLULAR SIGNALLING
- Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease
- (2010) Wenjun Ouyang CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-26: An IL-10-related cytokine produced by Th17 cells
- (2010) Raymond P. Donnelly et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells
- (2010) Roopali Gandhi et al. NATURE IMMUNOLOGY
- T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt
- (2010) Vanja Lazarevic et al. NATURE IMMUNOLOGY
- An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis
- (2010) F. J. Quintana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
- (2009) Erin E Longbrake et al. Expert Review of Neurotherapeutics
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- Compound A, a Plant Origin Ligand of Glucocorticoid Receptors, Increases Regulatory T Cells and M2 Macrophages to Attenuate Experimental Autoimmune Neuritis with Reduced Side Effects
- (2009) Z. Zhang et al. JOURNAL OF IMMUNOLOGY
- AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis
- (2009) Zhi-Yuan Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis
- (2009) Ann L. Cornish et al. Nature Reviews Rheumatology
- FTY720 attenuates lesional interleukin-17+cell accumulation in rat experimental autoimmune neuritis
- (2009) Z-Y. Zhang et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Valproic acid attenuates inflammation in experimental autoimmune neuritis
- (2008) Z. Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology
- (2008) Jan Piet van Hamburg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
- (2008) Xuexian O. Yang et al. IMMUNITY
- Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barré syndrome patients compared to controls
- (2008) J. Harness et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Regulation of inflammatory responses by IL-17F
- (2008) Xuexian O. Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
- (2008) Marc Veldhoen et al. NATURE
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
- (2008) Francisco J. Quintana et al. NATURE
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
- (2008) Liang Zhou et al. NATURE
- IL-21 and TGF-β are required for differentiation of human TH17 cells
- (2008) Li Yang et al. NATURE
- Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells
- (2008) Fuping Zhang et al. NATURE IMMUNOLOGY
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
- The Epidemiology of Guillain-Barré Syndrome Worldwide
- (2008) Anita McGrogan et al. NEUROEPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More